Cargando…

Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection

The increasing clinical importance of infections caused by multidrug resistant Acinetobacter baumannii warrants the development of novel approaches for prevention and treatment. In this context, vaccination of certain patient populations may contribute to reducing the morbidity and mortality caused...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Quintanilla, Meritxell, Pulido, Marina R., Pachón, Jerónimo, McConnell, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259314/ https://www.ncbi.nlm.nih.gov/pubmed/25485716 http://dx.doi.org/10.1371/journal.pone.0114410

Ejemplares similares

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
por: Carretero-Ledesma, Marta, et al.
Publicado: (2018)

Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells
por: Smani, Younes, et al.
Publicado: (2012)

Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection
por: Gil-Marqués, María Luisa, et al.
Publicado: (2018)

Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii
por: Labrador-Herrera, Gema, et al.
Publicado: (2020)

Peptidoglycan editing provides immunity to Acinetobacter baumannii during bacterial warfare
por: Le, Nguyen-Hung, et al.
Publicado: (2020)

Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB
por: Parra-Millán, Raquel, et al.
Publicado: (2018)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme
por: Kamoshida, Go, et al.
Publicado: (2020)

Acinetobacter baumannii Infection and IL-17 Mediated Immunity
por: Yan, Zihe, et al.
Publicado: (2016)

Host Innate Immune Responses to Acinetobacter baumannii Infection
por: Chen, Wangxue
Publicado: (2020)

Analysis of Immune Responses in Acinetobacter baumannii-Infected Klotho Knockout Mice: A Mouse Model of Acinetobacter baumannii Infection in Aged Hosts
por: Sato, Yoshinori, et al.
Publicado: (2020)

Designing Multi-Antigen Vaccines Against Acinetobacter baumannii Using Systemic Approaches
por: McConnell, Michael J., et al.
Publicado: (2021)

Pangenome of Acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation
por: Mangas, Eugenio L., et al.
Publicado: (2019)

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor
por: Gil-Marqués, María Luisa, et al.
Publicado: (2022)

Draft Genome Sequences of Seven Multidrug-Resistant Acinetobacter baumannii Strains, Isolated from Respiratory Samples in Spain
por: Labrador-Herrera, Gema, et al.
Publicado: (2016)

The Capsule of Acinetobacter baumannii Protects against the Innate Immune Response
por: Akoolo, Lavoisier, et al.
Publicado: (2022)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental Pneumonia
por: de Breij, Anna, et al.
Publicado: (2012)

The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections
por: García-Patiño, María Guadalupe, et al.
Publicado: (2017)

Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection
por: Shadan, Afreen, et al.
Publicado: (2023)

Role of peptidoglycan recycling enzymes AmpD and AnmK in Acinetobacter baumannii virulence features
por: Tajuelo, Ana, et al.
Publicado: (2023)

Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii
por: Olmeda-López, Héctor, et al.
Publicado: (2021)

Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii
por: Vinuesa, Víctor, et al.
Publicado: (2021)

Systematic Identification and Analysis of Acinetobacter baumannii Type VI Secretion System Effector and Immunity Components
por: Lewis, Jessica M., et al.
Publicado: (2019)

Acinetobacter baumannii Lipopolysaccharide Influences Adipokine Expression in 3T3-L1 Adipocytes
por: Unno, Yuka, et al.
Publicado: (2017)

Antigen Epitope Developed Based on Acinetobacter baumannii MacB Protein Can Provide Partial Immune Protection in Mice
por: Song, Xiaojie, et al.
Publicado: (2020)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection
por: Sheldon, Jessica R., et al.
Publicado: (2022)

Corrigendum: The Immune Response Against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections
por: García-Patiño, María Guadalupe, et al.
Publicado: (2022)

Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii
por: Piri-Gharaghie, Tohid, et al.
Publicado: (2023)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Acinetobacter baumannii
por: Cebrero-Cangueiro, T, et al.
Publicado: (2020)

Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii
por: Prieto Martin Gil, Sonia, et al.
Publicado: (2021)

Identification of Promoter Region Markers Associated With Altered Expression of Resistance-Nodulation-Division Antibiotic Efflux Pumps in Acinetobacter baumannii
por: López-Siles, Mireia, et al.
Publicado: (2022)

Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs
por: Kale, Sandeep D., et al.
Publicado: (2017)

Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
por: Chiang, Ming-Hsien, et al.
Publicado: (2020)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dsf22vj02gm3qbr1kk0gtokvs0